Retatrutide Peptide 5mg / 10mg | GLP-1 GIP Glucagon Triple Agonist

Retatrutide Peptide (RETA) is one of the most advanced compounds currentlyRetatrutide Peptide  studied in peptide research, featuring a triple-action mechanism targeting GLP-1, GIP, and glucagon receptors.

This multi-pathway activity positions Retatrutide as a next-generation evolution beyond both Semaglutide and Tirzepatide, makinghttps://rebirthlabs.org/ it one of the most exciting and high-demand compounds in metabolic and weight-related research.

It is widely selected in advanced research models focusing on:

• Metabolic regulation
• Energy expenditure pathways
• Appetite signaling systems
• Advanced endocrine studies

At rebirthpeptide.com, Retatrutide is supplied in high-purity lyophilized powder form, ensuring optimal stability and precision handling for laboratory research.

Retatrutide Peptide

• Triple agonist (GLP-1 + GIP + Glucagon)
• More advanced than Tirzepatide
• Extremely high demand in USA research market
• Positioned as “next-gen weight loss peptide”

• Reta is a multi-functional research peptide known for its activity in metabolic and energy regulation studies. It has been explored in various models related to weight management, body recomposition, and wellness optimization

• . Typical Research Applications:

  • Energy balance and appetite control models

  • Studies related to weight and fitness optimization

  • Wellness and aesthetic body management exploration

  Target Users:
  ✔️ Fitness and body transformation specialists
  ✔️ Wellness and anti-aging centers
  ✔️ Aesthetic medical clinics and beauty hospitals
  ✔️ Peptide sourcing agents and global resellers
  ✔️ Laboratories focused on body regulation studies

  Body composition and metabolic research

Product

• Product Name: Retatrutide (RETA)
• Strength Options: 5mg / 10mg / 15mg
• Form: Lyophilized powder
• Container: Sterile research vial
• Category: Triple Agonist Peptide
• Use: Research use only
• Storage: Refrigeration required